This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Glutamate receptor 3D structures
From Proteopedia
(Difference between revisions)
| (7 intermediate revisions not shown.) | |||
| Line 24: | Line 24: | ||
**[[5ybg]], [[5ybf]] - hIGluR2 LBD + potentiator + Glu<br /> | **[[5ybg]], [[5ybf]] - hIGluR2 LBD + potentiator + Glu<br /> | ||
**[[4u1y]], [[4u2p]], [[5l1b]] - rIGluR2 <br /> | **[[4u1y]], [[4u2p]], [[5l1b]] - rIGluR2 <br /> | ||
| + | **[[6dlz]], [[7rz9]] – rGluR2 – Cryo EM <br /> | ||
**[[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ-2 – Cryo EM<br /> | **[[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ-2 – Cryo EM<br /> | ||
**[[3n6v]], [[3o2j]], [[5n6p]] - rIGluR2 ATD (mutant) – rat<br /> | **[[3n6v]], [[3o2j]], [[5n6p]] - rIGluR2 ATD (mutant) – rat<br /> | ||
| Line 31: | Line 32: | ||
**[[3t93]], [[4u2r]] - rIGluR2 LBD (mutant)<br /> | **[[3t93]], [[4u2r]] - rIGluR2 LBD (mutant)<br /> | ||
**[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | **[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | ||
| + | **[[5kbs]], [[5kbt]], [[5kbu]] - rIGluR2 + antagonist – Cryo-EM<br /> | ||
**[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | **[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | ||
**[[6ucb]], [[6ud4]], [[6ud8]] - rIGluR2 + CNIH-3 + antagonist – Cryo-EM<br /> | **[[6ucb]], [[6ud4]], [[6ud8]] - rIGluR2 + CNIH-3 + antagonist – Cryo-EM<br /> | ||
| Line 47: | Line 49: | ||
*''GluR2 antagonist complex'' | *''GluR2 antagonist complex'' | ||
| + | **[[6peq]] - hIGluR2 + CNIH-3 + antagonist – Cryo EM<br /> | ||
**[[3r7x]], [[6fqk]], [[6fqj]], [[6fqi]] - hIGluR2 LBD + antagonist<br /> | **[[3r7x]], [[6fqk]], [[6fqj]], [[6fqi]] - hIGluR2 LBD + antagonist<br /> | ||
**[[6fqh]], [[6fqg]] - hIGluR2 LBD (mutant) + antagonist<br /> | **[[6fqh]], [[6fqg]] - hIGluR2 LBD (mutant) + antagonist<br /> | ||
| Line 52: | Line 55: | ||
**[[4u4g]], [[6u5s]], [[6u6i]] - rIGluR2 + antagonist<br /> | **[[4u4g]], [[6u5s]], [[6u6i]] - rIGluR2 + antagonist<br /> | ||
A [[Glutamate receptor (GluA2)|topic page]] describing in detail the [[Glutamate receptor (GluA2)|GluA2 structure described in 3kg2]]<br /> | A [[Glutamate receptor (GluA2)|topic page]] describing in detail the [[Glutamate receptor (GluA2)|GluA2 structure described in 3kg2]]<br /> | ||
| - | **[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]], [[6yk2]], [[6yk3]], [[6yk4]], [[6yk5]], [[6yk6]] - rIGluR2 LBD + antagonist<br /> | + | **[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]], [[6xsr]], [[6yk2]], [[6yk3]], [[6yk4]], [[6yk5]], [[6yk6]] - rIGluR2 LBD + antagonist<br /> |
**[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | **[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | ||
| + | **[[5wek]], [[7rz4]], [[7rz5]] – rGluR2 + antagonist – Cryo EM <br /> | ||
*''GluR2 agonist complex'' | *''GluR2 agonist complex'' | ||
| Line 61: | Line 65: | ||
**[[1lbc]], [[5elv]] - rIGluR2 LBD (mutant) + agonist + Glu<br /> | **[[1lbc]], [[5elv]] - rIGluR2 LBD (mutant) + agonist + Glu<br /> | ||
**[[2p2a]], [[5buu]], [[6hch]], [[6hcc]], [[6hcb]] - rIGluR2 LBD + agonist + Glu<br /> | **[[2p2a]], [[5buu]], [[6hch]], [[6hcc]], [[6hcb]] - rIGluR2 LBD + agonist + Glu<br /> | ||
| + | **[[7ryy]], [[7ryz]], [[7rz7]], [[7rz8]], [[7rza]] – rGluR2 + agonist – Cryo EM <br /> | ||
*''GluR2 partial agonist complex'' | *''GluR2 partial agonist complex'' | ||
| Line 75: | Line 80: | ||
*''GluR2 ligand complex'' | *''GluR2 ligand complex'' | ||
| + | **[[7f3o]] - hIGluR2 LBD + Glu + antagonist<br /> | ||
**[[3dp6]], [[2uxa]], [[2i3v]], [[2i3w]], [[1ftj]], [[4z0i]], [[4o3b]], [[6gl4]] - rIGluR2 LBD + Glu<br /> | **[[3dp6]], [[2uxa]], [[2i3v]], [[2i3w]], [[1ftj]], [[4z0i]], [[4o3b]], [[6gl4]] - rIGluR2 LBD + Glu<br /> | ||
**[[3b6q]], [[3b6w]], [[2gfe]], [[3t9x]], [[4u4s]], [[4u4x]], [[4yu0]], [[6giv]] - rIGluR2 LBD (mutant) + Glu<br /> | **[[3b6q]], [[3b6w]], [[2gfe]], [[3t9x]], [[4u4s]], [[4u4x]], [[4yu0]], [[6giv]] - rIGluR2 LBD (mutant) + Glu<br /> | ||
| Line 81: | Line 87: | ||
**[[4uqk]], [[4uqj]], [[4uq6]] - rIGluR2 + quisqualate – Cryo EM<br /> | **[[4uqk]], [[4uqj]], [[4uq6]] - rIGluR2 + quisqualate – Cryo EM<br /> | ||
**[[4wxj]] - DmIGluR2 LBD + Glu<br /> | **[[4wxj]] - DmIGluR2 LBD + Glu<br /> | ||
| + | |||
| + | *Ionotropic glutamate receptor 3 | ||
| + | |||
| + | **[[4zdm]] – GluR3 LBD + Gly – ''Pleurobrachia bachei''<br /> | ||
| + | |||
| + | *Ionotropic glutamate receptor 3.2 | ||
| + | |||
| + | **[[6x5q]] – AtIGluR3.2 LBD + Gly – ''Arabidopsis thaliana''<br /> | ||
*Ionotropic glutamate receptor 3.3 | *Ionotropic glutamate receptor 3.3 | ||
| - | **[[6r88]] – AtIGluR3.3 LBD | + | **[[6r88]] – AtIGluR3.3 LBD<br /> |
**[[6r85]] – AtIGluR3.3 LBD + Glu <br /> | **[[6r85]] – AtIGluR3.3 LBD + Glu <br /> | ||
**[[6r89]], [[6r8a]] – AtIGluR3.3 LBD + amino acid <br /> | **[[6r89]], [[6r8a]] – AtIGluR3.3 LBD + amino acid <br /> | ||
| + | |||
| + | *Ionotropic glutamate receptor 3.4 | ||
| + | |||
| + | **[[7lzi]] – AtIGluR3.4 – Cryo EM<br /> | ||
| + | **[[7lzh]] – AtIGluR3.4 + Glu – Cryo EM<br /> | ||
*Ionotropic glutamate receptor δ | *Ionotropic glutamate receptor δ | ||
| Line 95: | Line 114: | ||
**[[5l2e]] – rIGluRδ2 extracellular domain<br /> | **[[5l2e]] – rIGluRδ2 extracellular domain<br /> | ||
**[[6lu9]] – rIGluRδ2 extracellular domain – Cryo EM<br /> | **[[6lu9]] – rIGluRδ2 extracellular domain – Cryo EM<br /> | ||
| + | **[[7z2r]] – rIGluRd2 LBD <br /> | ||
**[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | **[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | ||
| - | *Ionotropic glutamate receptor 1+2 | + | *Ionotropic glutamate receptor 1+2 or AMPA receptor |
| - | **[[6qkz]], [[6qkc]] – rIGluR1 + rGluR2 + calcium channel g-8 – Cryo EM <br /> | + | **[[7occ]] – rIGluR1 + rGluR2 – Cryo EM <br /> |
| - | **[[6njl]] – rIGluR1 + rGluR2 + calcium channel | + | **[[6qkz]], [[6qkc]], [[7ocd]], [[7qhh]], [[8ayl]], [[8ayn]] – rIGluR1 + rGluR2 + calcium channel γ-8 – Cryo EM <br /> |
| + | **[[7oca]], [[7oce]], [[7ocf]] – rIGluR1 + rGluR2 + calcium channel γ-8 + CNIH2 – Cryo EM <br /> | ||
| + | **[[5weo]], [[7tnk]], [[7tnl]], [[7tnm]], [[7tnn]], [[7tno]], [[7tnp]] – rIGluR1/calcium channel g-8 + drug – Cryo EM <br /> | ||
| + | **[[6njl]] – rIGluR1 + rGluR2 + calcium channel γ-8 + SCFV + auxiliary protein + antibody – Cryo EM <br /> | ||
| + | **[[7ryz]], [[7rz8]] – rGluR2 + agonist – Cryo EM <br /> | ||
| + | **[[7rz5]] – rGluR2 + antagonist – Cryo EM <br /> | ||
| + | **[[7qhb]], [[7rz6]] – rGluR2 + Glu – Cryo EM <br /> | ||
| + | **[[6dm1]], [[6o9g]] – rGluR2 + Glu + inhibitor – Cryo EM <br /> | ||
| + | **[[6dm0]] – rGluR2 + Glu + drug – Cryo EM <br /> | ||
| + | **[[7tnj]] – rGluR2 + drug – Cryo EM <br /> | ||
| + | **[[6zyu]] – rGluR2 LBD + Glu + inhibitor<br /> | ||
**[[6ovd]], [[6ove]] – rIGluR1 + rGluR2 residues 415-821 + antagonist<br /> | **[[6ovd]], [[6ove]] – rIGluR1 + rGluR2 residues 415-821 + antagonist<br /> | ||
| + | **[[7ldd]], [[7lde]] – mIGluR1 + mGluR2 + calcium channel γ-8 + SCFV + antibody – Cryo EM <br /> | ||
*Ionotropic glutamate receptor 1+2+3 | *Ionotropic glutamate receptor 1+2+3 | ||
| Line 115: | Line 146: | ||
**[[5fwx]] – rIGluR2 ATD + rIGluR4 ATD <br /> | **[[5fwx]] – rIGluR2 ATD + rIGluR4 ATD <br /> | ||
| + | |||
| + | *Ionotropic glutamate receptor 1+2+3+4 | ||
| + | |||
| + | **[[7lep]] – rIGluR1 + rGluR2 + rIGluR3 + rGluR4 + calcium channel γ-8 + CNIH2 – Cryo EM <br /> | ||
*Ionotropic glutamate receptor 3 | *Ionotropic glutamate receptor 3 | ||
| Line 162: | Line 197: | ||
*Ionotropic kainate receptor 1 | *Ionotropic kainate receptor 1 | ||
| + | **[[7lvt]] – rGluK1 + Glu – Cryo EM<br /> | ||
**[[1ycj]] – rGluK1 LBD + Glu<br /> | **[[1ycj]] – rGluK1 LBD + Glu<br /> | ||
**[[5nf5]], [[5neb]] – rGluK1 LBD + Glu analog<br /> | **[[5nf5]], [[5neb]] – rGluK1 LBD + Glu analog<br /> | ||
| - | **[[3s2v]], [[4dld]], [[5m2v]], [[4ymb]], [[4qf9]], [[4mf3]], [[6fz4]] – rGluK1 LBD + antagonist<br /> | + | **[[3s2v]], [[4dld]], [[5m2v]], [[4ymb]], [[4qf9]], [[4mf3]], [[6fz4]], [[6sbt]] – rGluK1 LBD + antagonist<br /> |
**[[4e0x]] – rGluK1 LBD + kainate<br /> | **[[4e0x]] – rGluK1 LBD + kainate<br /> | ||
**[[5mfq]], [[5mfv]], [[5mfw]] – rGluK1 LBD + kainite + allosteric modulator<br /> | **[[5mfq]], [[5mfv]], [[5mfw]] – rGluK1 LBD + kainite + allosteric modulator<br /> | ||
| - | *Ionotropic kainate receptor 2 | + | *Ionotropic kainate receptor 2; LBD + TM 1-908 |
| + | **[[7f56]], [[7f57]], [[7f59]], [[7f5a]], [[7f5b]] - rGluK2 (mutant) + NETO2 – Cryo EM<br /> | ||
**[[3qxm]] - hGluK2 LBD + toxin<br /> | **[[3qxm]] - hGluK2 LBD + toxin<br /> | ||
**[[2xxr]] – rGluK2 LBD + Glu<br /> | **[[2xxr]] – rGluK2 LBD + Glu<br /> | ||
| Line 180: | Line 217: | ||
**[[1yae]], [[5kuf]] - rGluK2 LBD + agonist<br /> | **[[1yae]], [[5kuf]] - rGluK2 LBD + agonist<br /> | ||
**[[5kuh]] - rGluK2 LBD (mutant) + agonist<br /> | **[[5kuh]] - rGluK2 LBD (mutant) + agonist<br /> | ||
| + | **[[8fwq]], [[8fwr]] - rGluK2 LBD+TM + modulator – Cryo EM<br /> | ||
| + | **[[8fwv]], [[8fww]] - rGluK2 LBD+TM + modulator + drug – Cryo EM<br /> | ||
| + | **[[8fwt]] - rGluK2 LBD+TM + modulator + antagonist – Cryo EM<br /> | ||
**[[4uqq]] - rGluK2 ATD,LBD,TMD (mutant) + agonist<br /> | **[[4uqq]] - rGluK2 ATD,LBD,TMD (mutant) + agonist<br /> | ||
*Ionotropic kainate receptor 3 | *Ionotropic kainate receptor 3 | ||
| + | **[[6jfy]], [[6jfz]], [[6kzm]], [[6l6f]], [[7vm2]] - rGluK3 (mutant) – Cryo EM<br /> | ||
**[[3olz]] – rGluK3 ATD<br /> | **[[3olz]] – rGluK3 ATD<br /> | ||
**[[6fjz]], [[6fjy]] - rGluK3 extracellular domain (mutant)<br /> | **[[6fjz]], [[6fjy]] - rGluK3 extracellular domain (mutant)<br /> | ||
| Line 201: | Line 242: | ||
**[[3om0]], [[3om1]] – rGluK5 ATD<br /> | **[[3om0]], [[3om1]] – rGluK5 ATD<br /> | ||
| + | |||
| + | *Ionotropic kainate receptor 2+5 | ||
| + | |||
| + | **[[7ks3]] – rGluK2 + rGluK5 – Cryo EM<br /> | ||
| + | **[[7ks0]] – rGluK2 + rGluK5 + inhibitor – Cryo EM<br /> | ||
**[[3qlu]] - rGluK5 + rGluK2 (mutant)<br /> | **[[3qlu]] - rGluK5 + rGluK2 (mutant)<br /> | ||
**[[3qlv]] - rGluK5 + rGluK2 | **[[3qlv]] - rGluK5 + rGluK2 | ||
| Line 212: | Line 258: | ||
**[[3q41]] – rNMDAR N ATD <br /> | **[[3q41]] – rNMDAR N ATD <br /> | ||
**[[1y1m]], [[1y1z]], [[1y20]] – NMDAR LBD (mutant) + partial agonist<br /> | **[[1y1m]], [[1y1z]], [[1y20]] – NMDAR LBD (mutant) + partial agonist<br /> | ||
| - | **[[2hqw]] – NMDAR C terminal + calmodulin<br /> | ||
**[[1pb7]] – rNMDAR LBD + glycine<br /> | **[[1pb7]] – rNMDAR LBD + glycine<br /> | ||
**[[1pb8]], [[1pb9]] – rNMDAR LBD + serine<br /> | **[[1pb8]], [[1pb9]] – rNMDAR LBD + serine<br /> | ||
| Line 223: | Line 268: | ||
**[[2a5s]] - rNMDAR LBD + glutamate<br /> | **[[2a5s]] - rNMDAR LBD + glutamate<br /> | ||
| - | **[[4jwx]] – rNMDAR LBD + agonist<br /> | + | **[[4jwx]], [[6odl]] – rNMDAR LBD + agonist<br /> |
*''NMDAR subunit NR2B'' | *''NMDAR subunit NR2B'' | ||
| + | **[[7ujq]] - hNMDAR 1289-1310 + CAMK2A <br /> | ||
| + | **[[7kl0]], [[7kl2]], [[7uis]] - hNMDAR 1289-1310 (mutant) + CAMK2A <br /> | ||
| + | **[[7ujs]] - hNMDAR 1289-1310 + CAMK2A + ADP<br /> | ||
| + | **[[7ujp]] - hNMDAR 1289-1310 + CAMK2A + ATP<br /> | ||
| + | **[[7ujt]], [[7kl1]] - hNMDAR 1289-1310 (mutant) + CAMK2A + ATP<br /> | ||
**[[3jpy]], [[3jpw]] - rNMDAR ATD (mutant)<br /> | **[[3jpy]], [[3jpw]] - rNMDAR ATD (mutant)<br /> | ||
| - | **[[5up2]], [[5uow]] - XlNMDAR + NR2A + Fab + | + | **[[7ujr]] - rNMDAR 1289-1310 + CAMK2A <br /> |
| - | **[[5un1]] - XlNMDAR + methyl-aspartate receptor + | + | **[[5up2]], [[5uow]] - XlNMDAR + NR2A + Fab + Glu – Cryo-EM<br /> |
| + | **[[5un1]] - XlNMDAR + methyl-aspartate receptor + Glu <br /> | ||
*''NMDAR subunit NR3A'' | *''NMDAR subunit NR3A'' | ||
| Line 250: | Line 301: | ||
*''NMDAR subunit NR1+NR2A'' | *''NMDAR subunit NR1+NR2A'' | ||
| + | **[[7eos]], [[7eou]] – hNMDAR (mutant) – Cryo EM<br /> | ||
**[[5h8f]] – hNMDAR LBD <br /> | **[[5h8f]] – hNMDAR LBD <br /> | ||
**[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]], [[6mm9]], [[6mma]], [[6mmb]], [[6mmg]], [[6mmh]], [[6mmi]], [[6mmj]], [[6mmk]], [[6mml]], [[6mmm]], [[6mmn]], [[6mmp]], [[6mmr]], [[6mms]], [[6mmt]], [[6mmu]], [[6mmv]], [[6mmw]], [[6mmx]] – rNMDAR – Cryo EM <br /> | **[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]], [[6mm9]], [[6mma]], [[6mmb]], [[6mmg]], [[6mmh]], [[6mmi]], [[6mmj]], [[6mmk]], [[6mml]], [[6mmm]], [[6mmn]], [[6mmp]], [[6mmr]], [[6mms]], [[6mmt]], [[6mmu]], [[6mmv]], [[6mmw]], [[6mmx]] – rNMDAR – Cryo EM <br /> | ||
| Line 258: | Line 310: | ||
**[[5tpa]], [[5tp9]] – hNMDAR LBD + antagonist<br /> | **[[5tpa]], [[5tp9]] – hNMDAR LBD + antagonist<br /> | ||
| + | **[[7eoq]], [[7eor]], [[7eot]] – hNMDAR (mutant) + antagonist – Cryo EM<br /> | ||
**[[5kdt]], [[5kcj]] – hNMDAR LBD + modulator<br /> | **[[5kdt]], [[5kcj]] – hNMDAR LBD + modulator<br /> | ||
**[[5tpa]], [[5tp9]], [[5kdt]], [[5kcj]], [[5i2n]], [[5i2k]], [[5h8q]], [[5h8n]], [[5h8h]] – hNMDAR LBD + allosteric modulator<br /> | **[[5tpa]], [[5tp9]], [[5kdt]], [[5kcj]], [[5i2n]], [[5i2k]], [[5h8q]], [[5h8n]], [[5h8h]] – hNMDAR LBD + allosteric modulator<br /> | ||
| Line 279: | Line 332: | ||
**[[5tpz]] – rNMDAR LBD <br /> | **[[5tpz]] – rNMDAR LBD <br /> | ||
**[[6wi0]] – rNMDAR + antagonist – Cryo EM <br /> | **[[6wi0]] – rNMDAR + antagonist – Cryo EM <br /> | ||
| + | **[[7te9]], [[7teb]], [[7tee]], [[7teq]], [[7tes]] – rNMDAR + antibody – Cryo EM <br /> | ||
| + | **[[7eu7]], [[7eu8]], [[7sac]] – rNMDAR + ketamine + Glu – Cryo EM <br /> | ||
| + | **[[7saa]] – rNMDAR + Glu – Cryo EM <br /> | ||
| + | **[[7sab]] – rNMDAR + PCP – Cryo EM <br /> | ||
| + | **[[7sad]] – rNMDAR + drug – Cryo EM <br /> | ||
**[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | **[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | ||
**[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | **[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | ||
| Line 285: | Line 343: | ||
**[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | **[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | ||
**[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | **[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2C'' | ||
| + | |||
| + | **[[8e94]], [[8e97]] – hNMDAR – Cryo EM <br /> | ||
| + | **[[8e92]], [[8e93]], [[8e96]], [[8e98]] – hNMDAR + Glu + cyclo-Ser – Cryo EM <br /> | ||
| + | **[[7yfh]] – rNMDAR + Glu + Gly – Cryo EM <br /> | ||
| + | |||
| + | ''NMDAR subunit NR1+NR2D'' | ||
| + | |||
| + | **[[7yfo]], [[7yfr]] – hNMDAR – Cryo EM <br /> | ||
| + | **[[7yff]] – rNMDAR + CPP + Gly – Cryo EM <br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2A+NR2C'' | ||
| + | |||
| + | **[[8e99]] – hNMDAR + nanobody – Cryo EM <br /> | ||
*''NMDAR subunit NR1B+NR2B'' | *''NMDAR subunit NR1B+NR2B'' | ||
| - | **[[6wi1]] – rNMDAR – Cryo EM <br /> | + | **[[6wi1]], [[6whr]], [[6whs]], [[6wht]], [[6whu]], [[6whv]] – rNMDAR – Cryo EM <br /> |
**[[6whw]], [[6whx]], [[6why]] – rNMDAR + antagonist – Cryo EM <br /> | **[[6whw]], [[6whx]], [[6why]] – rNMDAR + antagonist – Cryo EM <br /> | ||
| + | **[[7ter]], [[7tet]] – rNMDAR + antibody – Cryo EM <br /> | ||
| + | **[[7te6]] – rNMDAR ATD + antibody <br /> | ||
| + | **[[8g18]] – rNMDAR ATD + inhibitor<br /> | ||
| - | *NMDAR subunit NR1+NR2A+NR2B | + | *''NMDAR subunit NR1B+NR2D'' |
| + | |||
| + | **[[7yfm]] – rNMDAR + Glu + Gly – Cryo EM <br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2A+NR2B'' | ||
**[[5up2]], [[5uow]] – XlNMDAR + antibody – Cryo EM<br /> | **[[5up2]], [[5uow]] – XlNMDAR + antibody – Cryo EM<br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2A+NR2C'' | ||
| + | |||
| + | **[[7yfi]] – rNMDAR + Glu + Gly – Cryo EM <br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D structures of glutamate receptor
Updated on 12-June-2023
A topic page describing in detail the GluA2 structure described in 3kg2
NMDAR subunit NR1+NR2D
